Sunitinib shown to improve disease-free survival in people with kidney cancer

, Homepage FeatureSunitinib shown to improve disease-free survival in people with kidney cancer

Results frounknownm the S-TRAC study were presented at the European Society of Medical Oncology. (ESMO) congress in Copenhagen this week. The results show that sunitinib  improved disease-free survival in patients with localised kidney cancer  that had been surgically removed; a group considered high-risk for relapseRead more

2016-10-12T16:54:40+00:00October 11th, 2016|Clinical Trials, Homepage Feature|
This website uses cookies and third party services to provide a better service. Please confirm you are okay with this. I agree